159 related articles for article (PubMed ID: 24443788)
21. RSK-mediated nuclear accumulation of the cold-shock Y-box protein-1 controls proliferation of T cells and T-ALL blasts.
Gieseler-Halbach S; Meltendorf S; Pierau M; Weinert S; Heidel FH; Fischer T; Handschuh J; Braun-Dullaeus RC; Schrappe M; Lindquist JA; Mertens PR; Thomas U; Brunner-Weinzierl MC
Cell Death Differ; 2017 Feb; 24(2):371-383. PubMed ID: 28009354
[TBL] [Abstract][Full Text] [Related]
22. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.
Janz M; Harbeck N; Dettmar P; Berger U; Schmidt A; Jürchott K; Schmitt M; Royer HD
Int J Cancer; 2002 Jan; 97(3):278-82. PubMed ID: 11774277
[TBL] [Abstract][Full Text] [Related]
23. Cold shock Y-box binding protein-1 acetylation status in monocytes is associated with systemic inflammation and vascular damage.
Ewert L; Fischer A; Brandt S; Scurt FG; Philipsen L; Müller AJ; Girndt M; Zenclussen AC; Lindquist JA; Gorny X; Mertens PR
Atherosclerosis; 2018 Nov; 278():156-165. PubMed ID: 30278358
[TBL] [Abstract][Full Text] [Related]
24. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
25. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
[TBL] [Abstract][Full Text] [Related]
26. Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.
Nishio S; Ushijima K; Yamaguchi T; Sasajima Y; Tsuda H; Kasamatsu T; Kage M; Ono M; Kuwano M; Kamura T
Gynecol Oncol; 2014 Mar; 132(3):703-8. PubMed ID: 24486603
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of YB-1 levels in patients with endometriosis.
Ahrens T; Silveira CG; Banz-Jansen C; Rody A; Hornung D
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():68-71. PubMed ID: 26093350
[TBL] [Abstract][Full Text] [Related]
28. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
29. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.
Yasen M; Kajino K; Kano S; Tobita H; Yamamoto J; Uchiumi T; Kon S; Maeda M; Obulhasim G; Arii S; Hino O
Clin Cancer Res; 2005 Oct; 11(20):7354-61. PubMed ID: 16243807
[TBL] [Abstract][Full Text] [Related]
30. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
31. [YB-1 protein expression in ovarian cancer].
Tarkowski R; Polak G; Nowakowski A; Wertel I; Kotarski J
Ginekol Pol; 2006 Jun; 77(6):458-62. PubMed ID: 16964697
[TBL] [Abstract][Full Text] [Related]
32. Nuclear Y-Box-binding Protein-1 Expression Predicts Poor Clinical Outcome in Stage III Colorectal Cancer.
Shiraiwa S; Kinugasa T; Kawahara A; Mizobe T; Ohchi T; Yuge K; Fujino S; Katagiri M; Shimomura S; Tajiri K; Sudo T; Kage M; Kuwano M; Akagi Y
Anticancer Res; 2016 Jul; 36(7):3781-8. PubMed ID: 27354655
[TBL] [Abstract][Full Text] [Related]
33. Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era.
Hanzawa K; Momose S; Higashi M; Tokuhira M; Watanabe R; Kajino K; Hino O; Itoyama S; Kizaki M; Tamaru J
Leuk Lymphoma; 2010 Nov; 51(11):2054-62. PubMed ID: 20929326
[TBL] [Abstract][Full Text] [Related]
34. High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients.
Miédougé M; Devys A; Simon M; Rouzaud P; Salama G; Reyre J; Pujazon M; Carles P; Serre G
Tumour Biol; 2001; 22(1):19-26. PubMed ID: 11054023
[TBL] [Abstract][Full Text] [Related]
35. Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience.
Wen YH; Chang PY; Hsu CM; Wang HY; Chiu CT; Lu JJ
Clin Chim Acta; 2015 Oct; 450():273-6. PubMed ID: 26344337
[TBL] [Abstract][Full Text] [Related]
36. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
[TBL] [Abstract][Full Text] [Related]
37. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J
J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488
[TBL] [Abstract][Full Text] [Related]
38. Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).
Lou L; Wang J; Lv F; Wang G; Li Y; Xing L; Shen H; Zhang X
Cell Oncol (Dordr); 2021 Feb; 44(1):109-133. PubMed ID: 32894437
[TBL] [Abstract][Full Text] [Related]
39. YB-1, a new biomarker of glioma progression, is associated with the prognosis of glioma patients.
Zheng J; Dong W; Zhang J; Li G; Gong H
Acta Biochim Biophys Sin (Shanghai); 2016 Apr; 48(4):318-25. PubMed ID: 26936129
[TBL] [Abstract][Full Text] [Related]
40. The expression level and prognostic value of Y-box binding protein-1 in rectal cancer.
Zhang Y; Zhao PW; Feng G; Xie G; Wang AQ; Yang YH; Wang D; Du XB
PLoS One; 2015; 10(3):e0119385. PubMed ID: 25790262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
